NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-1076.86%
↓ 124% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-480.64%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -1076.86% | -103.2% |
| 2024 | -530.00% | +57.8% |
| 2023 | -1255.22% | -5670.6% |
| 2022 | -21.75% | - |
| 2021 | 0.00% | - |
| 2020 | 0.00% | - |